Medivir AB (publ) (LON:0GP7)
London · Delayed Price · Currency is GBP · Price in SEK 1.950
0.00 (0.00%)
At close: Sep 3, 2025
Medivir AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 3.98 | 3.48 | 7.63 | 4.41 | 25.54 | 13.95 | Upgrade |
Other Revenue | - | - | - | - | 6.86 | 6.48 | Upgrade |
| 3.98 | 3.48 | 7.63 | 4.41 | 32.39 | 20.43 | Upgrade | |
Revenue Growth (YoY) | -42.54% | -54.36% | 73.16% | -86.39% | 58.56% | 134.18% | Upgrade |
Cost of Revenue | 73.47 | 101.27 | 68.87 | 69.08 | 73.28 | 52.93 | Upgrade |
Gross Profit | -69.49 | -97.79 | -61.23 | -64.67 | -40.88 | -32.5 | Upgrade |
Selling, General & Admin | 27.16 | 27.16 | 27.37 | 20.74 | 21.42 | 24.93 | Upgrade |
Other Operating Expenses | -0.01 | 0.39 | 1.41 | 0.63 | -0.49 | -1.05 | Upgrade |
Operating Expenses | 29.88 | 30.28 | 31.52 | 23.94 | 23.52 | 28.31 | Upgrade |
Operating Income | -99.37 | -128.07 | -92.75 | -88.61 | -64.4 | -60.81 | Upgrade |
Interest Expense | -3.51 | -0.78 | -0.91 | -0.93 | -0.95 | -0.55 | Upgrade |
Interest & Investment Income | - | 0.07 | 0.03 | 0.01 | - | 0.07 | Upgrade |
Currency Exchange Gain (Loss) | 0.73 | 0.73 | 1.34 | 1.22 | 1.6 | 1.29 | Upgrade |
Other Non Operating Income (Expenses) | -0.5 | - | 0 | - | 0 | 16.03 | Upgrade |
EBT Excluding Unusual Items | -102.65 | -128.05 | -92.3 | -88.31 | -63.75 | -43.98 | Upgrade |
Gain (Loss) on Sale of Investments | 4.73 | 4.73 | 2.98 | -0.49 | 0.49 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.04 | 0.68 | 1.36 | Upgrade |
Pretax Income | -97.92 | -123.32 | -89.32 | -88.77 | -62.58 | -42.62 | Upgrade |
Income Tax Expense | - | - | - | - | 0.55 | - | Upgrade |
Earnings From Continuing Operations | -97.92 | -123.32 | -89.32 | -88.77 | -63.13 | -42.62 | Upgrade |
Net Income | -97.92 | -123.32 | -89.32 | -88.77 | -63.13 | -42.62 | Upgrade |
Net Income to Common | -97.92 | -123.32 | -89.32 | -88.77 | -63.13 | -42.62 | Upgrade |
Shares Outstanding (Basic) | 115 | 114 | 60 | 56 | 53 | 24 | Upgrade |
Shares Outstanding (Diluted) | 115 | 114 | 60 | 56 | 53 | 24 | Upgrade |
Shares Change (YoY) | 28.57% | 88.71% | 8.44% | 5.53% | 117.45% | - | Upgrade |
EPS (Basic) | -0.85 | -1.08 | -1.48 | -1.59 | -1.20 | -1.75 | Upgrade |
EPS (Diluted) | -0.85 | -1.08 | -1.48 | -1.59 | -1.20 | -1.75 | Upgrade |
Free Cash Flow | -115.89 | -124.19 | -59.67 | -102.2 | -48.73 | -60.74 | Upgrade |
Free Cash Flow Per Share | -1.01 | -1.09 | -0.99 | -1.83 | -0.92 | -2.50 | Upgrade |
Gross Margin | - | - | - | - | -126.20% | -159.09% | Upgrade |
Operating Margin | -2494.23% | -3675.95% | -1215.16% | -2010.16% | -198.80% | -297.65% | Upgrade |
Profit Margin | -2457.76% | -3539.52% | -1170.21% | -2013.73% | -194.87% | -208.62% | Upgrade |
Free Cash Flow Margin | -2908.91% | -3564.61% | -781.67% | -2318.56% | -150.44% | -297.29% | Upgrade |
EBITDA | -99.24 | -127.94 | -92.62 | -88.4 | -64.08 | -59.2 | Upgrade |
EBITDA Margin | - | - | - | - | -197.81% | -289.77% | Upgrade |
D&A For EBITDA | 0.13 | 0.13 | 0.14 | 0.2 | 0.32 | 1.61 | Upgrade |
EBIT | -99.37 | -128.07 | -92.75 | -88.61 | -64.4 | -60.81 | Upgrade |
EBIT Margin | - | - | - | - | -198.80% | -297.65% | Upgrade |
Revenue as Reported | 5.16 | 4.46 | 9 | 6.23 | 35.74 | 41.26 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.